Celmatix Achieves Milestone for PCOS Drug Program

Jan 18

Written By Colleen McMillen

Colleen McMillen

Celmatix Announces Achievement of Key Preclinical Milestones in Premature Menopause Prevention Drug Program

Celmatix Appoints Merck R&D Veteran Stephen Palmer to Chief Scientific Officer Role